Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published.Research Areas Include:• Cell and molecular biology• Chemotherapy• Cytology• Endocrinology• Epidemiology• Genetics• Gynecologic surgery• Immunology• Pathology• Radiotherapy
《妇科肿瘤学》是一本国际性杂志，致力于发表有关女性生殖道肿瘤的临床和研究文章。研究领域包括：·细胞和分子生物学·化学疗法·细胞学·内分泌学·流行病学·遗传学·妇科手术·免疫学·病理学·放射疗法
Validation of the 2018 FIGO cervical cancer staging system.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2018.10.026
Disparities in gynecologic cancer genetics evaluation.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.01.024
Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.02.026
Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.03.255
GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients.
来源期刊：Gynecologic oncologyDOI：10.1016/J.YGYNO.2019.10.009
Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.02.023
Endocrine treatment of high grade serous ovarian carcinoma; quantification of efficacy and identification of response predictors.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2018.11.030
Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.02.007
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.10.023
Apatinib exerts anti-tumour effects on ovarian cancer cells.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.01.010
Efficacy and safety of niraparib as maintenance treatment in older patients (≥\u202f70\u202fyears) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2018.12.009
Results from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancer.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.05.003
A prospective clinical cohort study of women at increased risk for endometrial cancer.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.09.014
Phase III trials in ovarian cancer: The evolving landscape of front line therapy.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.02.008
A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.07.010
Novel treatment options in platinum-sensitive recurrent ovarian cancer: A review.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2018.10.023
MUC16 suppresses human and murine innate immune responses.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2018.12.023
A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2018.12.002
Pathological process has a crucial role in sentinel node biopsy for vulvar cancer.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.02.012
Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinoma
来源期刊：Gynecologic OncologyDOI：10.1016/j.ygyno.2019.09.001
Role of adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.05.028
Comparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2018.10.044
Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2018.12.027
A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2018.12.008
Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: A plausible early event in cervical squamous cell carcinoma development.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.07.023
Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.01.001
Non-pegylated liposomal doxorubicin (NPLD, Myocet®)\u202f+\u202fcarboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2018.10.043
Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.07.009
Risk factors for failure of bilateral sentinel lymph node mapping in early-stage cervical cancer.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.10.027
Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.02.005
Health-related quality of life in locally advanced cervical cancer patients treated with neoadjuvant therapy followed by radical surgery: A single-institutional retrospective study from a prospective database.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.07.005
Using next-generation sequencing (NGS) platform to diagnose pathogenic germline BRCA1/2 mutations from archival tumor specimens.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.08.027
Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.04.684
The influence of long non-coding RNAs on the response to chemotherapy in ovarian cancer.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.12.020
Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.02.004
Evidence-based wound classification for vulvar surgery: Implications for risk adjustment.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.06.008
MTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.08.014
Extramammary Paget disease of the vulva: Management and prognosis.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.11.009
Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgery.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.06.015
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.10.019
Shaping the standard of care in ovarian cancer management: A review of Gynecologic Oncology Group (GOG)/NRG oncology clinical trials of the past twenty years.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.02.020
Impact of perioperative red blood cell transfusion on postoperative recovery and long-term outcome in patients undergoing surgery for ovarian cancer: A propensity score-matched analysis.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.12.006
Survival disparities in vulvar cancer patients in Commission on Cancer®-accredited facilities.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.11.025
Evolving population-based statistics for rare epithelial ovarian cancers.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.11.122
Place of death by region and urbanization among gynecologic cancer patients: 2006-2016.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.07.013
Step-by-step demonstration of laparoscopic laterally extended endopelvic resection for a recurrent endometrial cancerous tumor at a sciatic foramen, with a detailed explanation of the pelvic sidewall anatomy.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.11.015
Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma
来源期刊：Gynecologic OncologyDOI：10.1016/J.YGYNO.2019.04.407
Variation in resource utilization associated with the surgical management of ovarian cancer.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2018.12.013
The effect of adjuvant chemotherapy on survival in patients with FIGO stage I high-grade serous ovarian cancer.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.03.257
Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience.
来源期刊：Gynecologic oncologyDOI：10.1016/j.ygyno.2019.06.001
